Dr. Khurshid Ahad Guru, MD

Dr. Guru practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Guru's NPI, 1568443117, was assigned on November 10, 2005. Dr. Guru graduated from J.J.M. Medical College in 1994. Dr. Guru holds New York license 237472-1.

Dr. Guru's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Guru's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Guru is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center. Dmand AI also links Dr. Guru to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guru practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Guru's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Guru is board certified in urology by the American Board of Urology. Dmand AI has Dr. Guru's licenses on file in 2 states: New York and Michigan.

Dmand AI lists bladder removal, erectile dysfunction, prostate surgery, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. Guru treats.

CMS data shows 152 Medicare services from Dr. Guru across 5 procedure codes in 2024, for 123 Medicare patients. Medicare paid $19,334 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Guru in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Guru's median patient age at 72, with 13% women.

In 2024, Dr. Guru wrote 23 Medicare Part D claims for 21 patients. 91% of them were for generic drugs. They cover 3 drugs, with $280 in total drug cost. In 2017, CMS named 14 claims across 1 drug.

Dr. Guru accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of prostate resection by Dr. Guru, more than 88% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 187 papers to Dr. Guru, published from 2007 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Urinary Bladder Neoplasms, Cystectomy and Robotic Surgical Procedures. Dr. Guru has published most often in BJU Int. Dr. Guru's most frequent co-authors are James O. Peabody, MD, Umar Iqbal, MD and Naif Abdullah Aldhaam, MD.

Dmand AI links Dr. Guru to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Urinary Tract Infections and Prostatic Diseases. Roswell Park Cancer Institute sponsors the most, 2.

CMS Open Payments shows 8 general payments to Dr. Guru from 4 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 77% of the total. Intuitive Surgical, Inc. paid the most, $9,696.

Dmand AI lists 13 awards for Dr. Guru, most recently Top Docs of WNY in 2015.

Dr. Guru graduated from J.J.M. Medical College in 1994. Dr. Guru is a member of AUA, Cancer Society of Kashmir (CSK), Guru Charitable Foundation (GCF) and International Robotic Radical Cystectomy Consortium (IRCC).

Dr. Guru is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.